Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico.

Frontiers in public health·2026
Same author

Micro-costing for national-scale azithromycin mass drug administration to improve child survival in Niger.

PLOS global public health·2026
Same author

Cost-benefit analysis of interpersonal therapy and fluoxetine for treating depression and PTSD in primary care settings in Kenya.

BMC psychiatry·2026
Same author

Value-based prices of emerging disease-modifying therapies for Alzheimer's disease in 174 countries: a cost-effectiveness and threshold analysis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.

Frontiers in psychiatry·2026
Same author

Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence.

Exploratory research in clinical and social pharmacy·2026

相关实验视频

Updated: Jul 15, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

在撒哈拉以南非洲地区,在HAART之前的HIV预防.

Elliot Marseille1, Paul B Hofmann, James G Kahn

  • 1Institute for Health Policy Studies, Center for AIDS Prevention Studies, and AIDS Research Institute, University of California, San Francisco, Box 0936, San Francisco CA 94143, USA. emarseille@attbi.com

Lancet (London, England)
|June 5, 2002
PubMed
概括

在撒哈拉以南非洲,优先考虑艾滋病毒预防而不是治疗,最大限度地提高健康效益并挽救生命. 投资预防计划比资助高活性抗逆转录病毒疗法 (HAART) 更具成本效益.

科学领域:

  • 公共卫生 公共卫生
  • 流行病学 流行病学
  • 卫生经济学 卫生经济学

背景情况:

  • 撒哈拉以南非洲地区的艾滋病毒/艾滋病大流行需要每年大量资金,估计为92亿美元.
  • 目前对联合国全球基金的资金承诺远远低于所需的数额.
  • 在预防艾滋病毒和高活性抗逆转录病毒疗法 (HAART) 之间平衡资金是一个关键的挑战.

研究的目的:

  • 分析艾滋病毒预防与撒哈拉以南非洲的HAART的成本效益.
  • 为了证明资金分配对死亡率的影响.
  • 推最佳的资源配置,以最大限度地提高艾滋病毒控制的健康益处.

主要方法:

  • 对艾滋病毒预防策略和HAART进行了比较性成本效益分析.
  • 模拟不同融资场景对获得的生命年数的影响.
  • 审查当前的艾滋病毒/艾滋病资金水平和要求.

主要成果:

  • 预防艾滋病毒的成本效益至少是HAART的28倍.
  • 以预防为代价,为HAART分配资金会导致更大的生命损失.
  • 目前的资金不足,仅有1960亿美元的承诺,而每年920亿美元的需求.

更多相关视频

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

相关实验视频

Last Updated: Jul 15, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

结论:

  • 未来在撒哈拉以南非洲地区增加艾滋病毒资金应优先考虑预防和非HAART护理.
  • 应该将HAART资金留给示范项目,直到实现广泛的人口预防覆盖.
  • 为了有效应对艾滋病毒,实现920亿美元的年度支出目标至关重要.